Can Fite Biopharma Ltd ADR
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|
Revenue | $179 | $179 | $158 |
Gross Profit | 179 | 179 | 158 |
EBITDA | -2,015 | -2,015 | -2,046 |
EBIT | -2,017 | -2,017 | -2,046 |
Net Income | -1,961 | -1,961 | -1,978 |
Net Change In Cash | 179 | 179 | 158 |
Free Cash Flow | -1,801 | -1,801 | -2,019 |
Cash | 4,825 | 4,825 | 4,719 |
Basic Shares | 8,435 | 8,435 | 6,071 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $674 | $743 | $810 | $853 |
Gross Profit | 674 | 743 | 810 | 853 |
EBITDA | -8,123 | -8,180 | -10,082 | -12,828 |
EBIT | -8,130 | -8,195 | -10,096 | -12,842 |
Net Income | -7,880 | -7,634 | -10,236 | -12,595 |
Net Change In Cash | 674 | 743 | 810 | 853 |
Free Cash Flow | -7,642 | -8,442 | -10,810 | -9,869 |
Cash | 4,825 | 4,278 | 2,978 | 4,390 |
Basic Shares | 7,253 | 4,261 | 2,719 | 1,843 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | $0 |
2023-12-31 | -$1.49 |
2023-09-30 | -$0.44 |
2023-06-30 | -$0.42 |
